Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 4
Submit an article Journal homepage
259
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Utility of 18F-FDG-PET/CT in lymphoblastic lymphoma

Thomas A Foxa Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UKCorrespondence[email protected] [email protected]
,
Ben Carpentera Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK
,
Mary Tajb Department of Clinical Haematology, Royal Marsden Hospital NHS Foundation Trust, London, UK
,
Martha Perisogloub Department of Clinical Haematology, Royal Marsden Hospital NHS Foundation Trust, London, UK
,
Emma Nicholsonb Department of Clinical Haematology, Royal Marsden Hospital NHS Foundation Trust, London, UK
,
Anna Castletonc Department of Clinical Haematology, The Christie Hospital NHS Foundation Trust, Manchester, UK
,
Johnathon Elliotc Department of Clinical Haematology, The Christie Hospital NHS Foundation Trust, Manchester, UK
,
Ben Uttenthald Department of Clinical Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
,
Callum Wrightd Department of Clinical Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
,
Richard Halseye Department of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK
,
Asim Khwajaa Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK;f UCL Cancer Institute, University College London, London, UK
,
Victoria Grandagea Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK
,
Marc R Mansoura Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK;f UCL Cancer Institute, University College London, London, UK
,
Adele K Fieldinga Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK;f UCL Cancer Institute, University College London, London, UK
&
Rachael Hougha Department of Clinical Haematology, University College London Hospitals NHS Foundation Trust, London, UK
 show all
Pages 1010-1012 | Received 14 Aug 2020, Accepted 12 Nov 2020, Published online: 04 Dec 2020

References

  • Cortelazzo S, Ferreri A, Hoelzer D, et al. Lymphoblastic lymphoma. Crit Rev Oncol Hematol. 2017; May;113:304–317.
  • Campana D. Minimal residual disease in acute lymphoblastic leukemia. Semin Hematol. 2009;46(1):100–106.
  • Ngeow JY, Quek RH, Ng DC, et al. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma. Ann Oncol. 2009;20(9):1543–1547.
  • Karantanis D, Durski JM, Lowe VJ, et al. 18F-FDG PET and PET/CT in Burkitt's lymphoma. Eur J Radiol. 2010;75(1):e68–e73.
  • Tsukamoto N, Kojima M, Hasegawa M, et al. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification. Cancer. 2007;110(3):652–659.
  • Elstrom R, Guan L, Baker G, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood. 2003;101(10):3875–3876.
  • Lepretre S, Touzart A, Vermeulin T, et al. Pediatric-like acute lymphoblastic leukemia therapy in adults with lymphoblastic lymphoma: the GRAALL-LYSA LL03 study. J Clin Oncol. 2016;34(6):572–580.
  • Ellin F, Jerkeman M, Hagberg H, et al. Treatment outcome in T-cell lymphoblastic lymphoma in adults – a population-based study from the Swedish Lymphoma Registry. Acta Oncol. 2014;53(7):927–934.
  • Park JH, Pahk K, Kim S, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of T-lymphoblastic lymphoma patients. Oncol Lett. 2016;12(2):1620–1622.
  • Becker S, Vermeulin T, Cottereau AS, et al. Predictive value of 18F-FDG PET/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trial. Eur J Nucl Med Mol Imaging. 2017;44(12):2034–2041.
  • Kasamon YL, Wahl RL. FDG PET and risk-adapted therapy in Hodgkin’s and non-Hodgkin’s lymphoma. Curr Opin Oncol. 2008;20(2):206–219.
  • La Fougere C, Hundt W, Brockel N, et al. Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin’s disease and non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging. 2006;33(12):1417–1425.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.